本指南包括实验室评估新试剂批次的建议，基于使用患者样本检测当前批次的临床重要变化的协议。

This guideline includes recommendations for laboratories on evaluating a new reagent lot, based on a protocol that uses patient samples to detect clinically important changes from the current lot.